LabCorp Is Scheduled to Present at the Bank of America 2007 Health Care Conference

BURLINGTON, N.C., May 30, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T.

LabCorp to Be First Commercial Laboratory to Offer FDA Approved, Fully Automated Real-Time HIV Test from Roche Diagnostics

New Test Format Will Help Doctors Tailor Patient Treatment, Enhance Total Quality Process and Simplify Testing BURLINGTON, N.C., May 21, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), one of the world's leading clinical laboratories, today announced an

LabCorp(R) Licenses Integrated and Sequential Prenatal Screening Technology for Down Syndrome from Intema

More Sensitive Technology Improves Assessment of Down Syndrome Risk BURLINGTON, N.C., May 16, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), an industry leader in prenatal clinical laboratory testing, announced today that it has entered into an

LabCorp(R) Scheduled to Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C.--(BUSINESS WIRE)--May 15, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 16, 2007 at 9:00 a.m. Eastern Time via the Company Web site at www.labcorp.com.

Laboratory Corporation of America(R) Holdings Announces 2007 First Quarter Results

First Quarter Net Sales Growth of 13.7% Drives Operating Cash Flow of $185.8 Million and EPS Increase of 28.9% BURLINGTON, N.C., April 26 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter ended March 31, 2007.

Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Essays

ROCKVILLE, Md. and BURLINGTON, N.C., April 25 /PRNewswire-FirstCall/ -- Celera (NYSE: CRA), an Applera Corporation business, and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), a national leader in esoteric and oncology testing, today announced that they have signed an

Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., April 16 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may

LabCorp's Liquid Yield Option(TM) Notes Due 2021 And Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Cash Interest

BURLINGTON, N.C., March 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that for the period of March 12, 2007 to September 11, 2007, its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021

LabCorp is Scheduled to Present at the Lehman Brothers 2007 Global Healthcare Conference

BURLINGTON, N.C., March 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and

LabCorp Announces $500 Million Stock Repurchase Program

BURLINGTON, N.C., March 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an aggregate of $500,000,000 of its Common